Introduction
Our current understanding of biological membranes has been shaped over the past 30 years by studies of membrane phase separation into ordered and disordered domains. Early on, these studies yielded the lipid raft hypothesis (1, 2) which was hotly debated in subsequent years (3) (4) (5) (6) (7) (8) . Based on a wealth of data it is now generally believed that phase separation does sometimes occur in sphingomyelin and cholesterol-rich membranes, such as in eukaryotic plasma membranes (PMs). While it is thought that phase-separated ordered are often small in size, transient, and similar to the adjacent disordered phase in lipid composition (8) (9) (10) , there also appear to be certain native membranes that are so cholesterol and sphingolipid-rich that their physical properties are, to a significant degree, akin to those of ideal liquid-ordered (Lo) phase model membranes (9, (11) (12) (13) Early studies of membrane protein association with raft-like ordered membrane domains was based largely on results involving the isolation of "detergent-resistant membranes" (14-17).
More recent biophysical studies conducted in intact phase-separated membranes have confirmed that a number of single-pass transmembrane proteins do indeed have a preference to partition into ordered phase domains relative to conjoined disordered phase domains.
Particularly important in this regard are studies that have employed "giant plasma membrane vesicles" (GPMVs), which can be formed from a variety of mammalian cell types (12) . When GPMVs are isolated and then cooled, separation of microscopically-observable ordered and disordered membrane phases can occur, allowing for quantitative studies of protein partitioning between the two phases (3, 12, (18) (19) (20) (21) . GPMVs therefore provide facile experimental access to conditions in which large and stable ordered phase domains co-exist with disordered membranes (18, 21, 22) . Groundbreaking studies of single span membrane proteins in this medium led to development of a convincing quantitative model describing the structural basis for why some proteins of this class preferentially partition into the ordered phase (12, 20, (23) (24) (25) (26) .
Studies of the phase preferences of multi-pass membrane proteins remain at a much earlier stage of development. Here, we present the first example of a multi-pass membrane protein that exhibits a pronounced preference for the ordered phase in GPMVs-the tetraspan peripheral myelin protein 22 (PMP22).
The human PMP22 is a 160-residue protein containing four transmembrane helices and intracellular N-and C-termini ( Fig. 1A) . PMP22 appears to play multiple roles in myelinating Schwann cells and peripheral myelin (27) (28) (29) (30) (31) including a critical role in cholesterol homeostasis, particularly in trafficking of cholesterol through the secretory pathway to the membrane surface (32) . This is especially important in Schwann cells given their specialized function as the factory for myelin production in the peripheral nervous system (PNS). Myelin membranes are unusually rich in both cholesterol and sphingolipids (33, 34) and are therefore highly ordered, as well suits their roles in providing electrical insulation and mechanical support to PNS axons. Mutations in the pmp22 gene result in >70% of all cases of Charcot-Marie-Tooth disease (CMTD, prevalence: 1:2500) and related peripheral neuropathies (28, 29, 35) . These closely related disorders are characterized by defective myelin membranes that contain altered cholesterol levels relative to healthy myelin (36) (37) (38) .
The involvement of PMP22 in cholesterol trafficking as part of the process of myelin membrane formation suggests that this protein might have an intrinsic affinity for ordered membrane domains. Indeed, it has previously been reported that PMP22 is found in "lipid raft" membranes isolated from neurons following application of classical detergent-extraction methods (34, 39) .
However, some of the methods used for preparing lipid rafts, including that used to identify PMP22 as a raft-associated protein, are thought to be artifact-prone (6, 7, (14) (15) (16) . Nevertheless, the likely role of PMP22 in Schwann cell cholesterol homeostasis combined with its residence in cholesterol and sphingolipid-rich myelin membranes dictate that the hypothesis that PMP22 may preferentially partition into ordered phase membranes is compelling. This hypothesis is tested in this work.
Results

PMP22 preferentially partitions into ordered phase membrane domains of GPMVs
To examine the preference of PMP22 for the ordered versus the disordered phase in plasma membranes (PM), we expressed human PMP22 ( Fig. 1A) in HeLa cells and then prepared GPMVs using established protocols (21) . To render PMP22 easily immunodetectable, the c-myc tag was inserted into the second extracellular loop, a modification that has no effect on PMP22 trafficking or function (40, 41) . PMP22 in GPMVs was visualized using confocal fluorescence microscopy using an anti-myc antibody conjugated to AlexaFluor 647 (AF647, green).
Disordered phase domains within GPMVs were identified using the fluorescent carbocyanine lipid DiIC12 (red), which partitions preferentially into disordered membrane domains (22) . Fig.   1B shows representative PMP22-containing GPMVs. Within each phase PMP22 was uniformly distributed and showed no tendency to concentrate at the boundary between the ordered and disordered domains ( Fig. 1B) .
In our experiments we noticed an increase in the amount of PMP22-containing GPMVs when preparations were performed using cells overexpressing the N41Q N-glycosylation deficient variant of PMP22 ( Fig. 1A , cyan) versus the wild type (WT) protein. Eliminating glycosylation of PMP22 does not affect its function or turnover (42, 43) . This observation is most likely due to an increased concentration of N41Q PMP22 at the PM compared to WT PMP22 (Fig. S2) .
Representative N41Q PMP22-containing GPMVs derived from both HeLa cells and primary rat
Schwann cells (RSCs) are also shown in Fig. 1B . Both glycosylated and non-glycosylated PMP22 show a clear preference for ordered phase membrane domains, as evidenced by the lack of co-localization of the red DiIC12 and green AF647 channels. PMP22 shows a distinct preference for ordered membrane domains in GPMVs prepared from both HeLa cells and RSCs.
AF647 fluorescence intensity was quantified in ordered and disordered GPMV membrane domains to determine the relative concentration of PMP22 in each membrane phase. Following image quantitation, the partitioning coefficient (P ordered ) of PMP22 was calculated, where P ordered is: [PMP22] ordered /([PMP22] ordered + [PMP22] disordered ), and ranges from 0 to 1 with a value of 0.5 meaning the protein has equal affinity for both phases, while P ordered > 0.5 means that the protein prefers the ordered phase, and P ordered < 0.5 means that the protein prefers the disordered phase. For an example of GPMV analysis see Fig. S1 (25) .
GPMVs from HeLa cells showed clear phase separation at 20 o C while those from RSCs exhibited phase separation at 15 o C. Quantification of P ordered for WT and N41Q PMP22 in GPMVs derived from HeLa cells as well as for N41Q PMP22 in GPMVs derived from RSCs is shown in Fig. 1C . Data was acquired from three independent biological experiments for each condition. In HeLa GPMVs, WT PMP22 showed a P ordered of 0.78±0.12 (mean ± SD) and N41Q PMP22 showed a P ordered of 0.79±0.10. N41Q PMP22-containing RSC GPMVs displayed a P ordered of 0.82±0.14. As a control, we measured the phase partitioning in both HeLa cells and RSC GPMVs of the well-studied mEGFP-labeled form of the single pass membrane protein, linker for activated T Cells (tgLAT) (Fig. S3 ). The measured P ordered values of 0.54±0.11 and 0.55±0.07 for tgLAT in GPMVs derived from Hela and RSCs respectively are in line with those reported in the literature using the same GPMV preparation in rat basal leukemia cells (20, 24) .
Additionally, we measured P ordered for N41Q PMP22 in HeLa GPMVs using a different membrane phase marker, NBD-DSPE ( Fig. S4) , which identifies ordered membrane phase domains (22) . Using this marker, we calculated a P ordered of 0.82±0.06. These results quantitatively demonstrate that PMP22 has a significant preference to partition into ordered membrane domains in GPMVs from both model mammalian cell lines and primary Schwann cells. Additionally, this phase preference is not affected by N-linked glycosylation. There were no significant differences in WT versus N41Q PMP22 phase partitioning. In light of this results and because the level of surface expression for N41Q PMP22 made it easier to image, all subsequent experiments reported in this work utilized a N41Q PMP22 variant (hereto referred to as "PMP22" for the sake of simplicity). Additionally, because HeLa-derived GPMVs showed phase separation at a temperature closer to physiological levels and were easier to transfect compared to RSCs, all subsequent experiments utilized HeLa derived GPMVs.
S-Palmitoylation of PMP22 is not a significant driver of its ordered phase preference
It was recently shown that PMP22 is palmitoylated at Cys85 (Fig. 1A, green) (44) . In that study this post-translational addition of a saturated fatty acid group on the cytosolic side of the protein was shown not to affect PMP22 processing/trafficking but is important for modulating epithelial cell shape and motility. For single pass transmembrane proteins, it has been repeatedly shown that palmitoylation plays a significant role in mediating membrane phase partitioning; one study estimated that this modification contributes ~0.5 kcal mol -1 free energy per chain in favor or ordered phase partitioning (20, 24) . The removal of palmitoylation from tgLAT disrupts the ordered phase preference of that protein and causes it to equally prefer both membrane phases (24) . We therefore tested to see if palmitoylation affects PMP22 partitioning into ordered membrane phases.
To eliminate the palmitoylation of PMP22 we mutated Cys85 to an Ala residue. This mutation did not affect the localization of PMP22 in HeLa cells ( Fig. S2) . We then measured the P ordered for C85A PMP22 in GPMVs. As seen in Fig. 2A -B palmitoylation did not drastically affect ordered phase preference of PMP22. We determined a P ordered for C85A PMP22 of 0.77±0.10.
This value is almost identical to that reported for WT and N41Q PMP22 in Fig. 1 . Because our method of GPMV preparation requires the use of the reducing agent dithiothreitol (DTT; 2 mM) we also set tested if PMP22 was still palmitoylated under these conditions. PMP22 transfected cells were incubated overnight with 100 mM of 17-octadecynoic acid (17-ODYA), a palmitic acid analogue containing an alkyne on the terminal carbon, which is known to be incorporated by thioesterases into palmitoylated proteins. Cells were then treated with or without 2 mM DTT for 90 min at 37 o C, lysed, and PMP22 was immunoprecipitated. We then added a biotin handle to palmitoylated proteins using biotin azide and classical 'click' chemistry (44) . Palmitoylated PMP22 was identified via western blotting using an anti-biotin antibody (Fig. 2C) . Palmitoylation was quantified as the intensity of the anti-biotin band over the anti c-myc band and normalized to the amount of palmitoylation found in N41Q PMP22 samples without DTT treatment (Fig.   2D ). As seen in Fig. 2C -D, treatment of HeLa cells for 90 minutes with 2 mM DTT did not affect PMP22 palmitoylation. As expected, C85A PMP22 was not palmitoylated in these experiments.
These results show that S-palmitoylation of PMP22 is not a significant driver of ordered phase preference.
Cholesterol binding motifs in PMP22 do not mediate its ordered phase preference
We next tested whether either or both of the predicted cholesterol binding sites in PMP22 play a role in its ordered phase preference. It has been shown that pmp22 -/-Schwann cells exhibit reduced plasma membrane levels and abnormal localization of cholesterol (30, 32) . These cells also show reduced migration, adhesion, and lamellipodia extension, all of which can be restored through external supplementation of cholesterol in the culture media. PMP22 contains both a classical cholesterol-recognition amino acid consensus (CRAC) motif in TM4 (L-X 1-5 -Y-X 1-5 -K) and an inverted CRAC (CARC) motif in TM3 (K-X 1-4 -Y-X 1-6 -I), as illustrated in orange in Fig. 1A .
While these motifs are loosely defined and are not always indicative of direct cholesterol interaction (45) , there is substantial experimental and computational evidence supporting the notion that these motifs are sometimes directly involved in binding cholesterol (46, 47) .
We mutated one or both of the essential Tyr residues in the CARC and CRAC motifs to Ala (Y97A, Y153A, and Y97A/Y153A mutants; Fig. 1A , purple). We then assessed the phase preference for each mutant in GPMVs. Mutation of Tyr97 had no effect on PM levels of PMP22 but mutation of Tyr153 or of both Tyr residues led to decreased PMP22 levels at the PM, suggesting lower expression and/or surface trafficking efficiency for these mutants (Fig. S2) .
Nevertheless, the mutations did not significantly alter the ordered phase preference of PMP22 ( Fig. 3A-B ). Y97A exhibited a P ordered of 0.83±0.10, Y153A exhibited a P ordered of 0.81±0.13, and the double mutant Y97A/Y153A yielded a P ordered of 0.71±0.15. P ordered for the double mutant is only slightly reduced. We interpret these results to indicate that the presence of CRAC and/or CARC motifs are not significant drivers of the preference of PMP22 for ordered phase domains.
Possible role for TM1 in determining the phase preference of PMP22
Since palmitoylation and cholesterol interaction motifs do not appear to play a major role in defining the phase preference of PMP22, we hypothesized that there is something intrinsic to the structure of the protein that drives its preferential association with the ordered phase.
Perhaps the most unusual structural feature of PMP22 is its first transmembrane helix (TM1), which is relatively long at 26 residues and lacks any polar residues at its N-terminus. The first 6 residues of PMP22 are also the first 6 residues of TM1: Met-Leu-Leu-Leu-Leu-Leu-. It is odd for the absolute N-terminus of a membrane protein to be part of the first TM segment.
We conducted genetic "intolerance analysis" of human PMP22 to measure the missense tolerance ratios (MTR), (48, 49) shows MTR analysis results for PMP22.
Overall, PMP22 is seen to be generally tolerant of missense mutations, reflecting the fact that while mutations in PMP22 cause disease, the disease is not fatal and usually does not eliminate reproductive capacity. However, the one region of the protein seen to be relatively intolerant to gene variations in the human population is the N-terminus of TM1 (red trace Fig. 4A ). The combined importance and distinctive features of TM1 led to the hypothesis that this segment might be important in helping to define the ordered phase domain preference of PMP22.
We first tested the effect of adding a conventional cytosolic anchor to the TM1 segment of PMP22. A positively charged segment (-Arg-Arg-Gly-Gly-) was added between the native Nterminal Met residue and the penta-Leu repeat follows at the start of TM1. This generated an "N-Anchor" mutant form of PMP22 ( Fig. 1A, N -Anchor). The addition of this anchor was seen to have no effect on PMP22 cellular localization, as this variant predominately localized to the cell surface in fixed cell images similar to WT-like N41Q PMP22 (Fig. S2) . When we then measured the phase preference of the N-Anchor mutant in GPMVs we observed a modest but significant reduction in P ordered to 0.64±0.11 ( Fig. 4B-C ) compared to N41Q PMP22 (P ordered =0.74±0.08 in experiments performed in parallel). Addition of the N-anchor to PMP22 reduces but does not eliminate its preference for the ordered phase.
We next tested the phase preference of PMP22 containing a disease mutation in TM1: the L16P variant ( Fig. 1A, red) , which is also known as the "Trembler-J" mutation because of its mouse phenotype (28, 29, 41) . Under WT/mutant heterozygous conditions L16P PMP22 causes severe demyelination in both human and mice. Moreover, biophysical studies on L16P PMP22 in detergent micelles showed that the L16P mutation introduces a flexible hinge in the helix, destabilizing the fully folded form of the protein and causing it to adopt an unfolded or folding intermediate state in which TM1 is disassociated from TM2-4, which remain bundled, but as a molten-globule (41, 50, 51) . While introduction of the L16P mutation exhibits significantly reduced cell surface expression compared to N41Q PMP22 ( Fig. S2) , we still were able to generate enough L16P PMP22 containing GPMVs to measure its phase preference. For L16P PMP22 we determined P ordered to be 0.32±0.17 ( Fig. 4B-C) . Thus, the L16P mutation dramatically reverses the phase preference of PMP22 such that the protein now prefers to partition into disordered membrane phase domains. This result suggests that the formation of stable tertiary structure in WT PMP22 is important for its ordered phase preference.
Since the CMTD causing L16P mutation was shown to reverse the membrane phase preference of PMP22, we decided to test the phase partitioning of two other disease-causing mutations located in other transmembrane segments. The A67T point mutation is located at a site near the exoplasmic end of TM2. This mutation is known to induce a slight destabilization of the conformational stability of PMP22 (41) and causes a mild form of CMTD, hereditary neuropathy with liability to pressure palsies (HNPP) (28) . In GPMVs A67T PMP22 exhibited a P ordered of 0.59±0.10, a significant reduction of ordered phase preference compared to PMP22 (0.81±0.07, as measured in parallel experiments; Fig. 4D-E) . The T118M point mutation destabilizes the conformational stability of PMP22 to a much greater extent compared to A67T (41), but less so than the L16P mutation, and is known to cause a moderate form of CMTD (28) . In GPMVs, T118M PMP22 displayed a P ordered of 0.22±0.11, reflecting pronounced preference for disordered membrane phases ( Fig. 4D-E) . These results suggest that the tertiary structural stability of PMP22 is essential to the affinity of WT PMP22 for ordered membrane domainsmerely inserting all TM segments of the protein into the membrane correctly is not enough.
PMP22 alters the biophysical properties of GPMVs and promotes formation of ordered phase domains.
Because it has been shown that PMP22 is critical for the formation of stable membrane domains in Schwann cells (30) , we hypothesized that PMP22 may alter the stability of phase separation between ordered and disordered phase domains in GPMVs. To test this, we first determined the miscibility temperature (T Misc ) of PMP22-containing GPMVs compared to GPMVs derived from cells transfected with an empty vector ("MOCK" conditions; Fig. 5A ). T Misc is defined as the temperature at which 50% of the GPMVs exhibit phase separation (9, 12, 52) .
A higher T Misc suggests more stable phase-separated membrane domains. We collected images of >100 GPMVs at each temperature over temperatures ranging from 12.5˚C to 32.5˚C and calculated the fraction of phase-separated GPMVs at each temperature. Fitting this data to a sigmoidal curve allowed us to determine the T Misc of the GPMVs. The T Misc seen for empty GPMVs was similar to what has previously been reported (9, 52) . To validate that the increase in T Misc was not due to general overexpression of a TM protein at the plasma membrane, we measured the T Misc of tgLAT containing GPMVs (Fig. S6) . GPMVs containing tgLAT exhibited a T Misc of 18.4±0.4 o C, similar to MOCK conditions ( Fig. 5B) ,
suggesting that the T Misc increase of PMP22-containing GPMVs was not due to generic membrane protein overexpression. This result indicates that PMP22 stabilizes phase separation in GPMVs.
We also examined whether the presence of PMP22 increased the size of ordered phase domains in GPMVs. To do this we imaged a large number of GPMVs derived from cells transfected with either an empty vector or one encoding PMP22. For these images we measured the radii of individual GPMVs as well as the fraction of each GPMV that contained the disordered phase maker DiIC12. From this information we were able to calculate the relative size of ordered domains in GPMVs, as indicated in Fig. 5C (see Fig. S7 for raw values). We found that GPMVs derived from cells transfected with an empty vector contained ordered domains with an average circumference of 11.8±0.1 μm whereas GPMVs with PMP22 contained ordered domains with a circumference of 16.6±0.1 μm. This significant increase in size suggests that PMP22 is able to stabilize the ordered membrane domains of GPMVs.
Combined with the fact that PMP22 increases the T Misc of GPMVs, we conclude that PMP22 is able to alter the biophysical properties of GPMVs to promote formation of ordered phase domains.
Discussion
While there are a number of biochemical reports that identify membrane proteins founds to colocalize with biochemically isolated "lipid raft" cell fractions (53) (54) (55) , to the best of our knowledge this is the first work that quantitively demonstrates the ordered phase membrane domain preference of a multi-pass membrane protein in cell-derived GPMVs.
Factors contributing to the ordered phase domain preference of PMP22
Much effort has been devoted to understanding the driving forces of membrane phase preference for single-pass transmembrane proteins. Previous work culminated in an elegant paper published by the Levental group that provided a quantitative model describing the biochemical and biophysical features promoting ordered phase domain partitioning for singlepass transmembrane proteins (20) . Ordered phase domain partitioning of single-pass proteins is promoted by increasing length for the transmembrane helix, by the presence of one or more palmitoyl chains, and by the presence of small amino acid side chains in the fully membraneexposed TM segment, especially for the half that sits in the exoplasmic bilayer leaflet. Whether components of this model can be extrapolated to ordered phase-preferring multi-pass membrane proteins is not yet clear. However, this study of PMP22 represents an important step in exploring this question.
The results demonstrated that the tetraspan integral membrane protein PMP22 has a distinct preference to partition into ordered phase membrane domains of GPMVs derived from both HeLa and primary Schwann cells. Unlike ordered phase-preferring single-pass transmembrane proteins (20, 23, 24) , partitioning of PMP22 is not driven mainly by palmitoylation. Even though native PMP22 is palmitoylated, it retains its strong preference for the ordered phase even under conditions in which its palmitoylation site is mutated away. Our results demonstrate that this modification is not required for the ordered membrane phase preference of PMP22, as it seems to be for single-pass membrane proteins. Ordered phase partitioning of PMP22 was also found not to be associated with the putative CARC and CRAC cholesterol binding motifs present in PMP22.
The PMP22 TM1 segment appears to play a specific role in determining its phase preference, as addition of a hydrophilic anchor to the apolar N-terminal end of this helix (which also serves as the N-terminus for the entire protein) significantly reduced the preference of PMP22 for the ordered phase. We speculate that the lack of polar residues flanking the start of TM1 may enable WT PMP22's N-terminus to adapt more easily to the more rigid matrix and thicker transbilayer span of ordered phase membranes relative to the adjacent disordered phase.
Future work will be needed to test this possibility and explore possible alternative explanations.
We also observed that introduction of the L16P mutation in the middle of TM1 reversed the phase preference of PMP22 so that it now favors the disordered phase. We have previously shown that the L16P mutant converts the straight and uninterrupted WT TM1 helical segment into a pair of helices linked by a flexible hinge (50, 51) . This causes TM1 to dissociate from the other TM helices to favor a destabilized form of the protein in which TM2, TM3, and TM4 remain in contact as a molten globular bundle while TM1 is dissociated in the membrane, tethered to the rest of the protein by the TM1-TM2 loop.
In addition to L16P PMP22, we also tested the phase preference of other CMTD PMP22 mutant forms, A67T and T118M. We previously observed that each of these mutant forms of PMP22 are destabilized relative to WT (41) . Interestingly, we found that the A67T mutation, which induces only a modest decrease of the conformational stability of PMP22, also caused only a modest decrease in its preference for the ordered phase. A more severely destabilizing mutation, T118M, resembled L16P (also very destabilizing) by dramatically shifting its phase preference to favor the disordered membrane phase. For these mutants we hypothesize that this shift in phase preference is the consequence of the global destabilization of the tertiary fold of the protein, even though the unfolded form retains its correct tetraspan membrane topology.
That formation of correct tertiary structure by PMP22 is required for ordered phase partitioning indicates that that the folded structure of PMP22 has traits that favor ordered phase partitioning relative to the disordered phase. Examination of a homology/Rosetta model for the structure of PMP22 (50) suggest that two of its transmembrane helices may be longer than average (at least 26 residues each) and that the transmembrane domain has a fairly featureless surface. While there does not seem to the general preponderance of residues with small side chains in the exoplasmic half of the PMP22 transmembrane domain as appears to be a feature of ordered phase-preferring single-pass membrane proteins (20, 56) , the presence of a Ser-Ala-Ala-Ala segment at the exoplasmic end of TM3 is intriguing. The intracellular "domain" of PMP22 is another distinctive feature, being comprised only of the N-terminal amino group of Met1, a 4 residue loop connecting TM2 and TM3, and four charged residues that follow TM4. Testing whether any of these features are contributing factors to PMP22's ordered phase preference will require many additional experiments, which we hope are motivated by the result of this paper.
The preference of PMP22 for ordered phase membrane domains of cell-derived GPMVs does not extend to the L o phase of synthetic lipid vesicles
In previous work we showed that purified recombinant PMP22 can be reconstituted into giant unilamellar vesicles (GUVs) containing synthetic lipids (57) . Under GUV conditions in which the synthetic lipids separated into ideal L d and L o lipid phases, it was observed that PMP22 partitioned exclusively to the disordered L d phase. Why are the results for PMP22 partitioning in GPMVs at odds with what was observed in GUVs? Our results show that neither of the known post-translational modifications of PMP22, N-glycosylation at N41 or S-palmitoylation at C85, are required for the ordered phase preference of PMP22 in GPMVs, such that it can be ruled out that the lack of post-translational modifications of the recombinant PMP22 used in the earlier GUV studies is the basis for its L d phase preference. We suggest instead that the variance between the results from the GPMV and GUV studies point to the fact that the difference in order between phase-separated domains in cell-derived GPMVs is much reduced relative to GUVs comprised of a well-defined ternary mixture of synthetic lipids. This phenomenon has previously been documented for single span membrane proteins (8, 18, 58) . Given that the P ordered for PMP22 in GPMVs was seen in this work to be nearly 0.8 means that the energy by which PMP22 favors the ordered phase over the disordered phase in GPMVs is on the order of -RTln(4) = -0.8 kCal/mol. One can easily imagine that the highly-ordered packing that occurs in ideal L o phases (but only to a much lesser degree in GPMVs) would need to be disrupted to accommodate partitioning of a membrane protein and that this unfavorable energy contribution could easily reverse the overall energetics of partitioning in GUVs to favor the L d phase.
PMP22 stabilizes ordered phase domains and promotes their formation
While some proteins are thought to passively associate with raft-like domains, others can actively promote their formation by clustering raft components and stabilizing ordered domains (25, 59) . Proteins that modulate membrane order or fluidity also are capable of regulating phase separation (60, 61) . Here, we identify PMP22 as a new example of a protein that can directly stabilize ordered phase membrane domains.
PMP22-containing GPMVs exhibited a higher T Misc than GPMVs containing tgLAT or cells
transfected with an empty vector ( Fig. 5A-B, Fig. S5) . That phase separation persists at higher temperatures in GPMVs containing PMP22 suggests that this protein can directly stabilize ordered phase membrane domains (9) . This is consistent with previous results from studies of pmp22 -/-mice showing that the distribution of molecules typically associated with ordered phase membrane domains (such as cholesterol, and GM1 ganglioside) are decreased at the plasma membrane (30) . Moreover, Schwann cells isolated from these mice showed elongation and migration defects that could be corrected by external supplementation of the culture medium with cholesterol. Additionally, our results suggest that PMP22 is able to promote ordered domain formation. We showed that GPMVs containing PMP22 had ordered membrane domains on average ~5 μm larger than those in GPMVs without PMP22 (Fig. 5C) . This may be due to an increased concentration in cholesterol in PMP22-containing GPMVs since it has recently been shown that PMP22 is regulates cholesterol PM trafficking (32) . It seems likely that the mechanisms underpinning this regulatory function of PMP22, as well as its ability to promote ordered phase formation, is closely related to its preference to partition into ordered membrane phase domains.
Conclusions
We have documented PMP22 as the first multi-pass membrane protein to exhibit a preference to partition into the ordered phase of cell-derived GPMVs. This phase preference appears to be closely linked to its unusual TM1 and also requires not just correct membrane integration of its four transmembrane helices, but formation of correct tertiary structure. Additional experiments will be required to determine exactly what features of its folded structure confer its preference for the ordered phase. Moreover, it remains unclear just how many other multi-pass membrane proteins will share the phase domain preference of PMP22 and whether they will resemble PMP22 in terms of driving traits. It is hoped that the results of this work will inspire future studies of both PMP22 and other multi-pass membrane proteins to address these issues.
Materials and Methods
Materials
DiIC12 was purchased from Life Technology (Eugene, USA). NBD-PE was purchased from Avanti (Alabaster, USA). Anti-myc AlexaFluora-647, anti-biotin, and anti-myc were purchased 
Cloning
Human cDNA for PMP22 was subcloned into a pCDNA3.1 mammalian expression vector. To make PMP22 immunologically detectable we used QuickChange mutagenesis to insert a myc epitope into the second extracellular loop of PMP22 within the pCDNA3.1 vector (41) .
QuickChange mutagenesis was also used to introduce point mutations and insert the 'N-Anchor' 
Cell Culture and Transfections
HeLa and RSCs were cultured in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% pen/strep at 37 o C and 5% CO 2 . Culture medium for RSCs was supplemented with 2 µM forskolin (Sigma-Aldrich). ~24 hours prior to transfection, cells were plated so as to be 40-50% confluent at the time of transfection. Cells were transfected using FuGene Transfection Reagent (Promega, Madison USA) with a FuGene:DNA ratio of 3:1 in OptiMEM. 6 cm 2 plates were transfected with 1.5 µg DNA. The transfection medium was removed from cells ~12-15 hours post-transfection and cells were washed with DPBS and fresh culture media was added to each plate.
GPMV Preparation
36 hours after transfection, the medium was removed from cells and cells were washed three times with inactive GPMV buffer (10 mM HEPES, 150 mM NaCl, 2 mM CaCl 2 pH 7.4). Cells were consistently 70-80% confluent at the time of GPMV prep. Active GPMV buffer (GPMV buffer plus 2 mM DTT and 25 mM formaldehyde) was then added to the plates, and cells were incubated at 37 o C with gentle shaking (70 RPM) for 90 minutes. DiIC12 or NBD-PE was then added to the plates from a stock solution of 0.5 mg/mL in EtOH to a final concentration of 0.5 µg/mL and cells were gently rocked at room temperature for 15 minutes. The GPMV-containing supernatant was then decanted into 1.5 mL Eppendorf tubes, and an anti-myc AF647 mAb was added to the solution (1:750 uL dilution) and gently agitated in the dark at room temperature for at least 3 hours. GPMVs were then allowed to settle in the dark to the bottom of the tube at 4 o C for 2-24 hours (we observed no difference in GPMV quality whether we imaged immediately or at 24-hour post GPMV prep). 30 minutes prior to imaging, 270 µL of GPMV solution was pipetted from the bottom of the Eppendorf tube and sandwiched between 2 coverslips coated with 0.1% BSA and separated by a 0.5 mm thick silicone isolator (Electron Microscopy Sciences).
GPMV Imaging
GPMVs were imaged using a Zeiss LSM 510 confocal microscope using a 1. 
Measurement of Miscibility Temperature (T Misc )
5x5 tile scans of GPMV samples were imaged at 1X digital zoom at temperatures ranging from 12.5 o C to 32.5 o C. Images were then randomized and GPMVs were blindly and manually classified as being either phase-separated or containing a single uniform phase. The fraction of vesicles that were phase separated at each temperature was then calculated. Plotting %-phase separated versus temperature yielded a curve that was fit to a sigmoidal function and the miscibility temperature (T Misc ) was defined as the temperature at which 50% of GPMVs were phase separated. Three independent biological experiments were performed and >100 GPMVs were imaged and classified for each temperature of each repeat. Classifications were performed blindly to the temperature at which the images were collected.
Fixed-Cell Imaging
Cells were cultured on glass coverslips and transfected as described above. 36 hours post transfection, cells were fixed with 4% PFA and permeabilized with 0.25% Triton X-100. Cells were treated with 1 ug/mL of RNase (Sigma-Aldrich) and PMP22, as then detected with mouse anti-myc (1:500) and visualized with donkey anti-mouse AF-488 (Invitrogen; 1:500). Nuclei were stained with propidium iodide (Sigma-Aldrich; 0.33 µg/mL). Coverslips were mounted to a slide using ProLong Gold (Invitrogen) and allowed to dry for 24 hours. Cells were then imaged using the 40X objective on the Zeiss LSM 510 confocal microscope at an optical zoom of 3-4X. The optical slice was set to <1µM in each image.
Calculation of GPMV Ordered Domain Size
Images of GPMVs derived from cells transfected either with an empty or N41Q PMP22 pCDNA3.1 vector were collected in a high throughput manner on an ImageXpress Micro XL (Molecular Devices) using a 40X objective. MATLAB (MathWorks) was used to calculate the radius of each GPMV in pixels, and the percentage of GPMVs in the ordered phase using the DiIC12 dye to mark the ordered phase. The radius was converted from pixel to μm using the conversion factor of 0.34 μm:1 pixel for the 40X objective. The circumference of each GPMV was then calculated using the equation: circumference=2π*radius, and ordered domain size was calculated by multiplying the fraction of each GPMV that was in the ordered phase by its circumference.
Statistical Analysis
The nonparametric Mann-Whitney U test was used to compare pairs of data. Significance is reported when determined. GraphPad Prism was used to perform all statistical analysis.
Missense Tolerance Ratio
The MTR plot for PMP22 was generated using the online software MTR Viewer Version 2 Missense tolerance analysis of pmp22. The MTR for a 31 residue sliding window of pmp22 is shown via the black and red solid line plot. MTR values of 1.0 indicate that the frequency of missense mutations encoding an amino acid change in that segment is the same as seen for silent missense mutations in the same segment. An MTR value lower than 1.0 indicates the segment is subject to "purifying selection" meaning some degree of evolutionary intolerance within that segment to amino acid-changing mutations. MTR values highlighted in red are those for which the false discovery rate (FDR) is less than 0.1, indicating the deviation of the MTR value from 1 is statistically robust (48) (49) (50) . 
